Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.6.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.41NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BS.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.36NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.5.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.290NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.341NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.161NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.69 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.139NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.508NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.94NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.463NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.357NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.318NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.557NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.119NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.160NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
D.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.447NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.110.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.180NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.155NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.92NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.145NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.120NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.77NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AE.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.504NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.201NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.221NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.410NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.513NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.338NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.284NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.9.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.498NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.184NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.187NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
D.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AE.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used